Optimizing Intensive Chemotherapy Management in Secondary AML Through Academic Community Collaboration - Episode 4
Panelists discuss how involving patients and caregivers in the treatment decision-making process for secondary acute myeloid leukemia (AML) requires clear communication, education about options, and consideration of individual values and preferences to ensure informed and shared decision-making.
Video content above is prompted by the following: